US FDA creates new task force and ”blog” to increase transparency
This article was originally published in RAJ Devices
The US Food and Drug Administration, in order to increase transparency around its decision-making process, has established a task force that will look at ways to provide the public with useful and understandable information about the agency’s activities in a more timely and user-friendly format1.
You may also be interested in...
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.